Task: Answer Verification
Input (English): Question: Is the steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients affected by gender-related co-factors?
Answer: Atazanavir/ritonavir steady-state pharmacokinetics was comparable in men and women, despite gender-related significant differences in atazanavir dose/body weight. The administration of atazanavir/ritonavir is pharmacokinetically safe; 95% of all trough samples were above the recommended plasma concentration of 150 ng/mL.
Output (English): no